MOTCO’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-42
Closed -$1.42K – 927
2026
Q2
$1.42K Buy
+42
New +$1.4K ﹤0.01% 557
2020
Q2
– Sell
-695
Closed -$6K – 734
2020
Q1
$6K Hold
695
– – ﹤0.01% 482
2019
Q4
$7K Sell
695
-3,305
-83% -$29.5K ﹤0.01% 457
2019
Q3
$28K Buy
+4,000
New +$30.6K ﹤0.01% 360
2018
Q3
– Sell
-1,000
Closed -$24K – 577
2018
Q2
$24K Buy
+1,000
New +$20.4K ﹤0.01% 378
2013
Q4
– Sell
-880
Closed -$33K – 598
2013
Q3
$33K Hold
880
– – ﹤0.01% 338
2013
Q2
$34K Buy
+880
New +$34.3K ﹤0.01% 341

Other funds holding TEVA

MOTCO's TEVA Position: Q3 2026 in Review

MOTCO sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 42 shares — an estimated $1.42K sold.

MOTCO first reported a position in TEVA in Q2 2013 and held it in 7 quarters. The position peaked at $34K in Q2 2013. 288 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • MOTCO reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
  • MOTCO sold 42 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $1.42K.
  • MOTCO first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 7 quarters.
  • MOTCO's Teva Pharmaceutical Industries Limited position peaked at $34K in Q2 2013.
  • 288 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on MOTCO's 13F filing for Q3 2026, filed 9 Nov 2026.